Allurion Technologies (ALUR) Competitors $2.17 +0.02 (+0.69%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$2.19 +0.02 (+0.92%) As of 09/15/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. QTI, TELA, CTSO, SURG, PYPD, DXR, SRTS, APT, CTCX, and PSTVShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include QT Imaging (QTI), TELA Bio (TELA), Cytosorbents (CTSO), SurgePays (SURG), PolyPid (PYPD), Daxor (DXR), Sensus Healthcare (SRTS), Alpha Pro Tech (APT), Carmell (CTCX), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Its Competitors QT Imaging TELA Bio Cytosorbents SurgePays PolyPid Daxor Sensus Healthcare Alpha Pro Tech Carmell Plus Therapeutics Allurion Technologies (NYSE:ALUR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Is ALUR or QTI more profitable? QT Imaging has a net margin of 0.00% compared to Allurion Technologies' net margin of -158.30%. Company Net Margins Return on Equity Return on Assets Allurion Technologies-158.30% N/A -59.91% QT Imaging N/A N/A -65.94% Does the media favor ALUR or QTI? In the previous week, Allurion Technologies had 2 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for Allurion Technologies and 0 mentions for QT Imaging. QT Imaging's average media sentiment score of 0.00 beat Allurion Technologies' score of -0.01 indicating that QT Imaging is being referred to more favorably in the news media. Company Overall Sentiment Allurion Technologies Neutral QT Imaging Neutral Which has more risk and volatility, ALUR or QTI? Allurion Technologies has a beta of -0.46, suggesting that its stock price is 146% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its stock price is 120% less volatile than the S&P 500. Do institutionals and insiders hold more shares of ALUR or QTI? 21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 9.6% of Allurion Technologies shares are owned by company insiders. Comparatively, 75.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher earnings and valuation, ALUR or QTI? QT Imaging has lower revenue, but higher earnings than Allurion Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$32.11M0.53-$7.20M-$12.53-0.17QT Imaging$4.00M17.31-$4.03MN/AN/A Do analysts rate ALUR or QTI? Allurion Technologies currently has a consensus price target of $22.83, suggesting a potential upside of 949.81%. Given Allurion Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe Allurion Technologies is more favorable than QT Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50QT Imaging 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryQT Imaging beats Allurion Technologies on 7 of the 13 factors compared between the two stocks. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$16.77M$10.74B$5.80B$21.53BDividend YieldN/A1.86%5.73%3.50%P/E Ratio-0.1720.5674.8629.84Price / Sales0.5330.23543.0171.01Price / CashN/A25.0025.8118.13Price / Book-0.073.4313.254.65Net Income-$7.20M$210.63M$3.29B$999.94M7 Day Performance0.42%-1.46%0.07%1.08%1 Month Performance-9.56%1.65%4.60%4.53%1 Year Performance-84.70%-11.43%72.96%14.39% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies1.7909 of 5 stars$2.18+0.7%$22.83+949.8%-85.9%$16.77M$32.11M-0.17501Short Interest ↑Gap UpQTIQT ImagingN/A$2.48+0.8%N/A+388.0%$67.29M$4.00M0.00N/ATELATELA Bio2.6813 of 5 stars$1.62+1.9%$4.50+177.8%-40.4%$62.99M$69.30M-1.45120Positive NewsCTSOCytosorbents2.5186 of 5 stars$0.98+1.7%$5.50+459.9%-15.3%$60.60M$36.11M-5.78220Positive NewsSURGSurgePays3.1021 of 5 stars$2.76+0.7%$9.00+226.1%+81.5%$55.98M$60.88M-1.1140Negative NewsPYPDPolyPid3.502 of 5 stars$3.46+0.3%$12.40+258.4%-2.2%$54.85MN/A-0.9080Positive NewsShort Interest ↓DXRDaxor4.0779 of 5 stars$11.41+3.2%$25.00+119.1%+28.8%$53.50MN/A0.0037Short Interest ↓Gap UpSRTSSensus Healthcare2.6515 of 5 stars$3.23flat$8.00+147.7%-48.3%$53.10M$41.81M-53.8340APTAlpha Pro Tech2.7302 of 5 stars$4.89flatN/A-14.6%$51.21M$58.56M13.22120Positive NewsCTCXCarmellN/A$2.43-4.7%N/A+307.7%$50.80M$32.84K0.0014PSTVPlus Therapeutics3.2258 of 5 stars$0.48-2.8%$7.88+1,548.2%-72.1%$48.78M$5.82M-0.2120Short Interest ↑Gap Up Related Companies and Tools Related Companies QT Imaging Competitors TELA Bio Competitors Cytosorbents Competitors SurgePays Competitors PolyPid Competitors Daxor Competitors Sensus Healthcare Competitors Alpha Pro Tech Competitors Carmell Competitors Plus Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALUR Stock Alerts